Literature DB >> 16883457

Hyperfunctioning intrathyroidal parathyroid carcinoma.

Wiam I Hussein1, Tarek A El-Maghraby, Osama Al-Sanea.   

Abstract

Intrathyroidal parathyroid carcinoma is an exceedingly rare cause of primary hyperparathyroidism with difficulties in the diagnosis and management. We report a case of hypercalcemia from intrathyroidal parathyroid carcinoma in a 63-year-old Saudi female. She was diagnosed 2 years earlier with osteoporosis in a primary care clinic and was on alendronate since then. This year she was noted to have hypercalcemia, but in retrospect she had more than 10 years history of multiple medical problems related to hypercalcemia. Parathyroid 99mTc-SestaMIBI scintigraphy revealed parathyroid adenoma in the left inferior parathyroid gland. She had successful video-assisted parathyroidectomy that relieved most of her symptoms. The extreme rarity of such a case, the interesting clinical presentation and review of the literature are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883457

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature.

Authors:  Nadia De Falco; Giuseppe Santangelo; Fabrizio Chirico; Angelo Cangiano; Maria Giulia Sommella; Angelo Cosenza; Andrea Ronchi; Marina Accardo; Gianluca Pellino; Domenico Parmeggiani; Silvestro Canonico; Massimo De Falco
Journal:  BMC Endocr Disord       Date:  2021-04-07       Impact factor: 2.763

2.  Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature.

Authors:  Lizette Vila Duckworth; William E Winter; Mikhail Vaysberg; César A Moran; Samer Z Al-Quran
Journal:  Case Rep Pathol       Date:  2013-07-14

3.  Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid Lesion.

Authors:  Noran Alharbi; Sylvia L Asa; Marta Szybowska; Raymond H Kim; Shereen Ezzat
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-01       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.